Navigation Links
Olympus Unveils New Dissolvable Post Sinus Surgery Products
Date:1/5/2012

CENTER VALLEY, Pa., Jan. 5, 2012 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced the addition of a broad line of advanced, dissolvable sinus spacing and hemostat products to its already extensive ENT product portfolio. These products include spacers, foams and powders available in either plant-based or chitosan polysaccharide polymers.

Through a distribution partnership with Hemostasis, LLC, the plant-based and chitosan compositions have been formulated to improve post sinus surgery recovery, comfort and healing. All products are biocompatible, dissolve naturally, require no mixing or special storage considerations and are easily conformed to fit nasal anatomy. Additionally, the sinus products minimize edema, bleeding and prevent post operative adhesions by maintaining space between the upper chambers of the nasal cavities.  

"The new offerings extend Olympus' current world-class ENT solutions to surgeons performing sinus and anterior skull base procedures and their patients," commented Perry Mykleby, Vice President of Marketing for Olympus' ENT sales. "We are pleased to collaborate with Hemostasis, a high-quality medical device manufacturer partner, to enhance patient care."

"Hemostasis is committed to providing the most comprehensive, technologically advanced ENT sinus spacing and hemostat technologies that are safe and effective for their intended use," said Hemostasis' President, Keith Roberts. "Working directly with leading physicians, we have developed practical technologies designed to optimize physician usability and efficacy, which ultimately have improved procedure outcomes and enhances overall patient care."

About Olympus Medical Systems ENT Business
Olympus develops procedure solutions for healthcare professionals that help improve outcomes and enhance quality of life for their patients. Our ENT Business offers advanced visualization and treatment products for Rhinology, Pediatric ENT, Laryngology, Otology, Sleep and Head and Neck procedures. Products include endoscopy and video; powered electrosurgical and manual instruments, middle ear prosthetics, and vent (PE) tubes.

For more information about Olympus America, visit www.olympusamerica.com.
For more information about ENT products, click here.

About Hemostasis, LLC
Hemostasis is a dynamic company committed to developing and marketing innovative technologies for the rapidly changing demands of the global medical industry. We work directly with leading physicians to develop practical products that are designed to optimize usability and efficacy for medical professionals, improve procedure outcomes and enhance overall patient care. www.hemostasisllc.com.


'/>"/>
SOURCE Olympus America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Omnyx Licenses Olympus Digital Pathology Patents
2. Olympus America Licenses Digital Pathology Patents to BioImagene, Inc.
3. Olympus Launches 2011 National Innovation Awards Program
4. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
5. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
6. Gumz to Retire as President and CEO of Olympus Corporation of the Americas
7. Olympus Biotech Names Oliver Burckhardt to President North America
8. Olympus Introduces Worlds First Autoclavable 5mm HD Deflectable Videolaparoscope
9. Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection
10. Olympus Broadens Portfolio With a Suite of New Single-Use Aspiration Needles
11. Oregon Tourism Commission Unveils New Online Customer Service Training Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... May 26, 2016 TARE ... Both Cost Savings and Overall Decreased Use ... BTG), an international specialist healthcare company, has today ... 21st Annual Meeting of ISPOR (International Society for ... hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres is ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
(Date:5/25/2016)... HILDEN , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... into a licensing and co-development agreement with Therawis Diagnostics GmbH ... project will be to develop and market PITX2 as a ... and other high-risk breast cancer patients. "We are ...
Breaking Medicine Technology:
(Date:5/30/2016)... ... May 30, 2016 , ... Shaolin ... warrior 8-day-8 and 8-night special intensive summer training camp starts on June 17th ... camp offers families and children a fun and unique experience with an opportunity ...
(Date:5/29/2016)... ... May 29, 2016 , ... "With 30 unique self-animating ... user control the style of their project," said Christina Austin - CEO of Pixel ... web-themed intros created exclusively for use in Final Cut Pro X. Pixel Film Studios’ ...
(Date:5/28/2016)... ... May 28, 2016 , ... After a year and a half of planning the ... extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, 2016 ... and the United Kingdom came together to explore the many pathways individuals use to get ...
(Date:5/27/2016)... ... 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield ... (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields and ... of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and ...
(Date:5/27/2016)... ... May 27, 2016 , ... This campaign aims to provide ... we as a society can control and change. , As nearly 795,000 Americans suffering ... seconds within the United States. Plus, with an estimated 129,000 of these people dying ...
Breaking Medicine News(10 mins):